(64)Cu-DOTA-PR81

N/A

Report date: 2025/11/12 10:00:33

Base Information

Drug Name(64)Cu-DOTA-PR81

Drug Alias Name64Cu-DOTA-PR81[64Cu]-DOTA-PR81

ClassificationRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionAnti-MUC1

TargetsMucin-1

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIran

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNuclear Science and Technology Research Institute

China Registration ClassN/A

Develop Information

Active CompaniesNuclear Science and Technology Research Institute

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A